跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spravato - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Spravato
Approved
STANDARD
Spravato
Renaissance Lakewood LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dd8b12ead355616e
Company
Renaissance Lakewood LLC
Type
Standard
Approval Details
Approval Id
dd8b12ead355616e
Drug Approval Philippines Name
Spravato
Product Name
Spravato
Registration Number
DR-XY47611
Brand Name
Spravato
Generic Name
Esketamine (as hydrochloride)
Dosage Form
Nasal Solution (Spray)
Dosage Strength
28 mg
Manufacturer
Renaissance Lakewood LLC
Importer
Johnson & Johnson (Philippines), Inc.
Company Detail Path
/organization/renaissance-lakewood-llc
Issuance Date
16 December 2021
Expiry Date
16 December 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dd8b12ead355616e
Type
Standard
Back to Philippines FDA Approvals